Recombinant hepatitis B vaccine and the risk of multiple sclerosis
暂无分享,去创建一个
[1] Corri Black,et al. Validity of the General Practice Research Database , 2003, Pharmacotherapy.
[2] Robert T. Chen,et al. Vaccinations and risk of central nervous system demyelinating diseases in adults. , 2003, Archives of neurology.
[3] Disease Prevention. Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders , 2002 .
[4] A. Alpérovitch,et al. Hepatitis B Vaccination and First Central Nervous System Demyelinating Event: A Case-Control Study , 2002, Neuroepidemiology.
[5] A. Opaneye,et al. Audit of hepatitis B immunization at the genitourinary medicine department in Middlesbrough, UK , 2002, International journal of STD & AIDS.
[6] A. Compston,et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.
[7] M. Sturkenboom,et al. Vaccinations and multiple sclerosis. , 2001, The New England journal of medicine.
[8] C. Viboud,et al. Vaccinations and multiple sclerosis. , 2001, The New England journal of medicine.
[9] A. Alpérovitch,et al. Hepatitis B vaccine and first episodes of central nervous system demyelinating disorders: a comparison between reported and expected number of cases. , 2001, British journal of clinical pharmacology.
[10] A M Walker,et al. Hepatitis B vaccination and the risk of multiple sclerosis. , 2001, The New England journal of medicine.
[11] S. Dittmann. Special address: safety of hepatitis B vaccination. , 2000, Vaccine.
[12] A. Sadovnick,et al. School-based hepatitis B vaccination programme and adolescent multiple sclerosis , 2000, The Lancet.
[13] F. Zipp,et al. No increase in demyelinating diseases after hepatitis B vaccination , 1999, Nature Medicine.
[14] A. Hall,et al. Multiple sclerosis and hepatitis B vaccine? , 1999, Vaccine.
[15] C. Poser,et al. The epidemiology of multiple sclerosis: A general overview , 1994, Annals of neurology.
[16] D. Jamison,et al. Disease Control Priorities in Developing Countries , 1993 .
[17] H Jick,et al. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. , 1991, BMJ.
[18] D. Silberberg,et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.
[19] L. G. García Rodríguez,et al. Use of the UK General Practice Research Database for pharmacoepidemiology. , 1998, British journal of clinical pharmacology.
[20] L. Brosseau,et al. Drug abuse as a risk factor of multiple sclerosis: case-control analysis and a study of heterogeneity. , 1993, Neuroepidemiology.